Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report

Anticancer Res. 2008 Sep-Oct;28(5B):2987-90.

Abstract

Intrahepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Bile Duct Neoplasms / blood supply
  • Bile Duct Neoplasms / therapy*
  • Bile Ducts, Intrahepatic / blood supply
  • Bile Ducts, Intrahepatic / pathology*
  • Chemoembolization, Therapeutic / methods*
  • Cholangiocarcinoma / blood supply
  • Cholangiocarcinoma / therapy*
  • Female
  • Humans
  • Microspheres
  • Organoplatinum Compounds / administration & dosage*
  • Oxaliplatin

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin